Log in

NYSE:PFEPfizer Stock Price, Forecast & News

$34.51
+0.77 (+2.28 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$34.04
Now: $34.51
$34.85
50-Day Range
$32.04
MA: $35.37
$38.19
52-Week Range
$27.88
Now: $34.51
$44.56
Volume42.87 million shs
Average Volume35.31 million shs
Market Capitalization$191.70 billion
P/E Ratio12.33
Dividend Yield4.40%
Beta0.68
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Merck KGaA; licensing agreement with BionTech AG; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More
Pfizer logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.9Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.66 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71708110
Phone212-733-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$51.75 billion
Cash Flow$4.11 per share
Book Value$11.46 per share

Profitability

Net Income$16.27 billion

Miscellaneous

Employees88,300
Outstanding Shares5,554,830,000
Market Cap$191.70 billion
Next Earnings Date7/28/2020 (Confirmed)
OptionableOptionable

Receive PFE News and Ratings via Email

Sign-up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

Pfizer (NYSE:PFE) Frequently Asked Questions

How has Pfizer's stock been impacted by COVID-19 (Coronavirus)?

Pfizer's stock was trading at $32.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PFE shares have increased by 7.3% and is now trading at $34.51. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Pfizer?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Pfizer.

When is Pfizer's next earnings date?

Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Pfizer.

How can I listen to Pfizer's earnings call?

Pfizer will be holding an earnings conference call on Tuesday, July 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Pfizer's earnings last quarter?

Pfizer Inc. (NYSE:PFE) released its quarterly earnings results on Tuesday, April, 28th. The biopharmaceutical company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.09. The biopharmaceutical company had revenue of $12.03 billion for the quarter, compared to the consensus estimate of $11.38 billion. Pfizer had a net margin of 31.17% and a return on equity of 25.76%. Pfizer's revenue was down 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.85 earnings per share. View Pfizer's earnings history.

How often does Pfizer pay dividends? What is the dividend yield for Pfizer?

Pfizer announced a quarterly dividend on Thursday, June 25th. Stockholders of record on Friday, July 31st will be paid a dividend of $0.38 per share on Tuesday, September 1st. This represents a $1.52 annualized dividend and a dividend yield of 4.40%. The ex-dividend date of this dividend is Thursday, July 30th. View Pfizer's dividend history.

How will Pfizer's stock buyback program work?

Pfizer declared that its board has authorized a share buyback program on Friday, December 14th 2018, which authorizes the company to repurchase $10,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 3.8% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

What guidance has Pfizer issued on next quarter's earnings?

Pfizer issued an update on its FY20 earnings guidance on Tuesday, April, 28th. The company provided earnings per share guidance of $2.82-2.92 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.70. The company issued revenue guidance of $48.5-50.5 billion, compared to the consensus revenue estimate of $47.01 billion.

What price target have analysts set for PFE?

12 analysts have issued 12-month price objectives for Pfizer's stock. Their forecasts range from $24.00 to $53.00. On average, they anticipate Pfizer's stock price to reach $38.61 in the next year. This suggests a possible upside of 11.9% from the stock's current price. View analysts' price targets for Pfizer.

Has Pfizer been receiving favorable news coverage?

Media coverage about PFE stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pfizer earned a news impact score of -2.8 on InfoTrie's scale. They also assigned media coverage about the biopharmaceutical company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the stock's share price in the immediate future. View the latest news about Pfizer.

Who are some of Pfizer's key competitors?

What other stocks do shareholders of Pfizer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Verizon Communications (VZ), Intel (INTC), AbbVie (ABBV), General Electric (GE), Walt Disney (DIS), Bank of America (BAC) and Exxon Mobil (XOM).

Who are Pfizer's key executives?

Pfizer's management team includes the following people:
  • Mr. Ian C. Read, Exec. Chairman (Age 65)
  • Mr. Albert Bourla D.V.M., DVM, Ph.D., CEO & Director (Age 57)
  • Mr. Frank A. D'Amelio, CFO & EVP of Global Supply & Bus. Operations (Age 61)
  • Dr. Mikael Dolsten, Chief Scientific Officer & Pres of Worldwide Research, Devel. and Medical (Age 60)
  • Mr. John D. Young, Group Pres & Chief Bus. Officer (Age 54)

What is Pfizer's stock symbol?

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Who are Pfizer's major shareholders?

Pfizer's stock is owned by a number of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.04%), Park National Corp OH (0.01%), First Financial Bank Trust Division (0.00%), Thomasville National Bank (0.00%), Boltwood Capital Management (0.00%) and Cacti Asset Management LLC (0.00%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Jennifer B Damico, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman and Scott Gottlieb. View institutional ownership trends for Pfizer.

Which major investors are selling Pfizer stock?

PFE stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, M&R Capital Management Inc., Boltwood Capital Management, and Park National Corp OH. Company insiders that have sold Pfizer company stock in the last year include Douglas M Lankler, and Jennifer B Damico. View insider buying and selling activity for Pfizer.

Which major investors are buying Pfizer stock?

PFE stock was bought by a variety of institutional investors in the last quarter, including Modus Advisors LLC, First Financial Bank Trust Division, Thomasville National Bank, Cox Capital Mgt LLC, Cacti Asset Management LLC, and Nelson Van Denburg & Campbell Wealth Management Group LLC. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc, and Scott Gottlieb. View insider buying and selling activity for Pfizer.

How do I buy shares of Pfizer?

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pfizer's stock price today?

One share of PFE stock can currently be purchased for approximately $34.51.

How big of a company is Pfizer?

Pfizer has a market capitalization of $191.70 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis. Pfizer employs 88,300 workers across the globe.

What is Pfizer's official website?

The official website for Pfizer is www.pfizer.com.

How can I contact Pfizer?

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.